PRPH - ProPhase Labs, Inc.
0.3626
-0.085 -23.414%
Share volume: 5,493,740
Last Updated: 01-02-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$0.45
-0.08
-0.19%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-10-2024 | 08-14-2024 | 11-13-2024 | 05-20-2025 | 08-13-2025 | 11-19-2025 | |
| Cash flow financing | 2.271 M | 5.323 M | 2.856 M | 1.938 M | 261.000 K | 3.722 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -413.000 K | 629.000 K | -1.271 M | -590.000 K | 81.000 K | 0.000 | |
| Net income | -6.265 M | -6.153 M | -6.587 M | 3.966 M | -4.472 M | -6.839 M | |
| Depreciation | 1.686 M | 1.617 M | 2.390 M | 1.482 M | 1.349 M | 1.038 M | |
| Changes in inventories | -152.000 K | 0.000 | 0.000 | 2.000 K | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 2.435 M | 124.000 K | -97.000 K | 853.000 K | 67.000 K | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 939.000 K | 26.000 K | 97.000 K | -53.000 K | -67.000 K | 0.000 | |
| Cash Change | -413.000 K | 629.000 K | -1.271 M | -590.000 K | 81.000 K | 236.000 K |